• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Cytokine profiles dynamics in COVID-19 patients: a longitudinal analysis of disease severity and outcomes

tetano

Editor, Senior Moderator
Sci Rep


. 2025 Apr 23;15(1):14209.
doi: 10.1038/s41598-025-98505-y. Cytokine profiles dynamics in COVID-19 patients: a longitudinal analysis of disease severity and outcomes

Sara Ghaffarpour[SUP] 1 [/SUP], Tooba Ghazanfari[SUP] 2 3 [/SUP], Sussan Kaboudanian Ardestani[SUP] 1 4 [/SUP], Mohammad Mehdi Naghizadeh[SUP] 5 [/SUP], Mohammad Reza Vaez Mahdavi[SUP] 6 [/SUP], Mohammadreza Salehi[SUP] 7 [/SUP], Ali Mohammad Mohseni Majd[SUP] 1 [/SUP], Azadeh Rashidi[SUP] 1 [/SUP], Maryam Rajabnia Chenary[SUP] 1 [/SUP], Amrollah Mostafazadeh[SUP] 8 [/SUP], Abbas Rezaei[SUP] 9 [/SUP], Ali Khodadadi[SUP] 10 [/SUP], Sara Iranparast[SUP] 10 [/SUP], Hossein Ali Khazaei[SUP] 11 [/SUP]



Affiliations
Abstract

The outcome of the immune response depends on the content and magnitude of inflammatory mediators, the right time to start, and the duration of inflammatory responses. Patients with coronavirus disease 2019 (COVID-19) represent diverse disease severity. Understanding differences in immune responses in individuals with different disease severity levels can help elucidate disease mechanisms. Here, we serially analyzed the cytokine profiles of 809 patients with mild to critical COVID-19. The cytokine profile revealed an overall increase in IL-1β, IL-1Ra, TNF-α, IL-6, IL-2, IL-8, and IL-18 and impaired production of IFN-α and -β. Only an early rise in IL-1Ra, IL-6, and IL-2 levels was linked to worse disease outcomes. On the other hand, long-term rises in IL-1β, IL-1Ra, TNF-α, IL-6, IL-2, IL-8, and IL-18 levels were linked to worse disease outcomes. Principal component analysis identified a component, including IL-1β, TNF-α, IFN-α, and IL-12, that was associated with disease severity. Spearman analysis revealed that the correlation of IL-1β and IFN-α was entirely different between mild and critical patients. Therefore, the ratio of IL-1β to IFN-α seemed to be a suitable criterion for distinguishing critical patients from mild ones. The higher levels of the IL-1β to IFN-α ratio correlated with improved outcomes. These data point to an imbalance of IL-1β/IFNα, contributing to hyperinflammation in COVID-19.

Keywords: COVID-19; Cytokine profile; Longitudinal study; Principle component analysis.; SARS-CoV-2.

 
Back
Top Bottom